Astrotech Revenue Growth Rates (ASTC), Current and Historic Growth - CSIMarket
CSIMarket
 


Astrotech Corp  (NASDAQ: ASTC)
 

ASTC's Revenue Growth by Quarter and Year

Astrotech's Revenue results by quarter and year




ASTC Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March 0.34
2nd Quarter December 0.15
1st Quarter September 0.30
FY 0.79

ASTCs Annual Revenue
Astrotech's Revenue in the fiscal year 2025 $ 1.05 millions
Astrotech's Revenue in the fiscal year 2024 $ 1.66 millions
Astrotech's Revenue in the fiscal year 2023 $ 0.75 millions
Astrotech's Revenue in the fiscal year 2022 $ 0.87 millions
Astrotech's Revenue in the fiscal year 2021 $ 0.33 millions




ASTC Revenue third quarter 2026 Y/Y Growth Comment
Astrotech Corp reported fall in Revenue in the third quarter 2026 by -35.28% to $ 0.34 millions, from the same quarter in 2025.
The drop in the third quarter 2026 Astrotech Corp's Revenue compares unfavorably to the Company's average Revenue rise of 25.94%.

According to the results reported in the third quarter 2026, Astrotech Corp achieved the best Revenue growth in Laboratory Analytical Instruments industry. While Astrotech Corp' s Revenue drop of -35.28% ranks overall at the positon no. 408 in the third quarter 2026.




ASTC Revenue ( Y/Y Growth %) 2026
2025 2024 2023
4th Quarter June - 214.29 % -82.93 % 1950 %
3rd Quarter March -35.28 % 960 % 25 % -60 %
2nd Quarter December -42.31 % -76.79 % 330.77 % -53.57 %
1st Quarter September 900 % -93.02 % 975 % -78.95 %
FY   - -37.72 % 122.67 % -

Financial Statements
Astrotech's third quarter 2026 Revenue $ 0.34 millions ASTC's Income Statement
Astrotech's third quarter 2025 Revenue $ 0.53 millions Quarterly ASTC's Income Statement


ASTC Revenue (Quarter on Quarter Growth %)

2026
2025 2024 2023
4th Quarter June - -58.49 % 40 % 925 %
3rd Quarter March 128.67 % 103.85 % -95.54 % -84.62 %
2nd Quarter December -50 % 766.67 % 160.47 % 550 %
1st Quarter September 36.36 % -57.14 % 4.88 % 100 %
FY (Year on Year)   - -37.72 % 122.67 % -




Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #0
Healthcare Sector #105
Overall #408

Revenue Y/Y Growth Statistics
High Average Low
467.5 % 25.94 % -96.88 %
(Jun 30 2024)   (June 30. 2015)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #0
Healthcare Sector #105
Overall #408
Revenue Y/Y Growth Statistics
High Average Low
467.5 % 25.94 % -96.88 %
(Jun 30 2024)   (June 30. 2015)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Astrotech's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
20400 % 564.05 % -100 %
(Dec 31 2019)  


ASTC's III. Quarter Q/Q Revenue Comment
Astrotech Corp achieved in the III. Quarter 2026 below company average Revenue doubling of 128.67% quarter on quarter, to $ 0.34 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 103.85% in the III. Quarter a year ago.

Within Laboratory Analytical Instruments industry only one company achieved higher sequential Revenue growth. While Astrotech's Revenue growth quarter on quarter, overall rank is 87.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #2
Healthcare Sector #32
Overall #87
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #2
Healthcare Sector #32
Overall #87
Revenue Q/Q Growth Statistics
High Average Low
20400 % 564.05 % -100 %
(Dec 31 2019)  


ASTC's III. Quarter Q/Q Revenue Comment
Astrotech Corp achieved in the III. Quarter 2026 below company average Revenue doubling of 128.67% quarter on quarter, to $ 0.34 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 103.85% in the III. Quarter a year ago.

Within Laboratory Analytical Instruments industry only one company achieved higher sequential Revenue growth. While Astrotech's Revenue growth quarter on quarter, overall rank is 87.


Astrotech's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)
12 Months Ending
(Dec 31 2025)
12 Months Ending
(Sep 30 2025)
12 Months Ending
(Jun 30 2025)
12 Months Ending
(Mar 31 2025)
Cumulative Revenue 12 Months Ending $ 1.01 $ 1.20 $ 1.31 $ 1.05 $ 0.90
Y / Y Revenue Growth (TTM) 11.63 % 186.16 % 3.06 % -36.96 % -54.94 %
Year on Year Revenue Growth Overall Ranking # 110 # 181 # 67 # 26 # 70
Seqeuential Revenue Change (TTM) -15.93 % -8.61 % 25.07 % 16.17 % 115.51 %
Seq. Revenue Growth (TTM) Overall Ranking # 408 # 1800 # 2422 # 82 # 2917


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2026 period, Astrotech's cumulative twelve months Revenue were $ 1 millions, company would post below average annual Revenue growth of 115.51% year on year, if the fiscal year would end at Mar 31 2026.
A slow-down in the Astrotech's Revenue growth from the 0.15% growth in Dec 31 2025. Despite that, Astrotech showed the highest Revenue growth, among it's peers in Laboratory Analytical Instruments industry.

In the Healthcare sector 42 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 110, from total ranking in previous quarter at 181.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 0
Healthcare Sector # 43
Overall # 110

Revenue TTM Y/Y Growth Statistics
High Average Low
467.5 %
25.94 %
-96.88 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 0
Sector # 105
S&P 500 # 408
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2026 period, Astrotech's cumulative twelve months Revenue were $ 1 millions, company would post below average annual Revenue growth of -96.88% year on year, if the fiscal year would end at Mar 31 2026.
A slow-down in the Astrotech's Revenue growth from the 0.15% growth in Dec 31 2025. Despite that, Astrotech showed the highest Revenue growth, among it's peers in Laboratory Analytical Instruments industry.

In the Healthcare sector 42 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 110, from total ranking in previous quarter at 181.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 0
Healthcare Sector # 43
Overall # 110

Revenue TTM Y/Y Growth Statistics
High Average Low
467.5 %
25.94 %
-96.88 %
 






Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ASTC's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue doubling for the quarter ending Mar 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2026
Trisalus Life Sciences Inc -0.03%$ -0.035 millions
Adma Biologics Inc -0.30%$ -0.304 millions
Vaso Corporation-0.54%$ -0.545 millions
60 Degrees Pharmaceuticals Inc -0.92%$ -0.922 millions
Cytosorbents Corporation-0.95%$ -0.945 millions
Conmed Corporation-1.31%$ -1.310 millions
Neuropace Inc -1.32%$ -1.316 millions
Bio techne Corp-1.35%$ -1.353 millions
Schrodinger Inc -1.62%$ -1.619 millions
United Therapeutics Corporation-1.62%$ -1.624 millions
Prokidney Corp -1.74%$ -1.739 millions
Sarepta Therapeutics Inc -1.89%$ -1.887 millions
Fortrea Holdings Inc -2.27%$ -2.272 millions
Ultragenyx Pharmaceutical Inc -2.36%$ -2.363 millions
Teladoc Health Inc -2.47%$ -2.467 millions
Fonar Corporation-2.55%$ -2.551 millions
Puma Biotechnology Inc -2.59%$ -2.593 millions
Coya Therapeutics Inc -2.61%$ -2.612 millions
10x Genomics Inc -2.76%$ -2.763 millions
Plus Therapeutics Inc -2.93%$ -2.927 millions
Infusystem Holdings Inc-2.97%$ -2.973 millions
Solventum Corporation-3.04%$ -3.043 millions
Milestone Scientific Inc -3.15%$ -3.153 millions
Organon and Co -3.50%$ -3.503 millions
Fulgent Genetics Inc -3.89%$ -3.894 millions
Igc Pharma Inc -3.94%$ -3.939 millions
Carlisle Companies Incorporated-3.99%$ -3.988 millions
Harvard Bioscience Inc -4.44%$ -4.437 millions
Castle Biosciences Inc -4.90%$ -4.897 millions
Prestige Consumer Healthcare Inc -4.95%$ -4.953 millions


About Astrotech Revenue Growth Rates (ASTC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Astrotech Corp (CIK 1001907).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-26-016543
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Astrotech Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.